Committee for Veterinary Medicinal Products

Applications to establish MRLs for new pharmacologically active substances must be submitted to the European Medicines Agency (EMEA) at least 6 months in advance of an application for a marketing authorisation. In order to avoid delays, manufacturers are advised to submit an application once all the necessary data are available, as a product authorisation carmot be granted unless established MRLs are in place. The EMEA should be notified of the intent to submit an application 3 to 4 months in advance of the anticipated date, so that a Rapporteur and Co-Rapporteur can be appointed from among the members of the Committee for Veterinary Medicinal Products (CVMP). 

Table 3 Comparison of US FDA, US EPA, and EU Committee for Veterinary Medicinal Products (CVMP) method validation requirements...

Development and Validation of a Proposed Regulatory Method, EMEA/CVMP/573100, Vol. 8, Veterinary Medicinal Products Establishment of Maximum Residue Limits (MRLs) for Residues of Veterinary Products in Foodstuffs of Animal Origin, Committee for Veterinary Medicinal Products, London (2001). Also available on the World Wide Web http //www.emea.eu.int/pdfs/vet/swp/057300en.pdf. 

Committee for Veterinary Medicinal Products (EMEA) Department of Drug Registration (China)... 

The principal scientific bodies of the EMEA are the Committee for Proprietary Medicinal Products (CPMP) and the Committee for Veterinary Medicinal Products (CVMP). These committees have two members from each member state as well as from Norway and Iceland which are appointed to give independent scientific advice to the EMEA. 

Committee for Veterinary Medicinal Products (2003). Oxalic acid Summary report. Available from http //www.emea.eu.int/pdfs/vet/mrls/089103en.pdf [Accessed November 2007]. 

B. Perez, C. Prats, and M. Arboix, J. Vet. Pharmacol. Ther., 20 308 (1997). European Agency for the Evaluation of Medicinal Products (EMEA), in Nafcillin, Summary Report, Committee for Veterinary Medicinal Products, EMEA/MRL/147/... 

EAEMP (The European Agency for the Evaluation of Medicinal Plants.) (1998) Committee for Veterinary Medicinal Products. Atropa Belladonna. Summary Report. 

---